Source link : https://newshealth.biz/health-news/adding-anagliptin-to-insulin-and-metformin-enhances-t2d-care/
TOPLINE: Adding anagliptin, a DPP-4 inhibitor, to ongoing insulin and metformin therapy was well-tolerated and improved glycemic control at 24 weeks in patients with inadequately controlled type 2 diabetes (T2D). METHODOLOGY: Patients with T2D unresponsive to oral therapy often require insulin — yet basal or premixed insulin alone may not curb postprandial spikes, and adding […]
The post Adding Anagliptin to Insulin and Metformin Enhances T2D Care first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-02 05:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8